NCT03778554Active, not recruitingPhase 4
Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction
Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction (DANBLOCK)
Source: ClinicalTrials.gov · Last updated 10 Jun 2025
Brief summary (registry, in English)
To determine whether long-term treatment with oral betablocker therapy after myocardial infarction in patient with no heart failure reduces the composite outcome of recurrent MI, all-cause mortality, revascularisation with percutaneous coronary intervention or coronary artery bypass graft, ischemic stroke, incident heart failure, or malignant ventricular arrhythmia including resuscitated cardiac arrest of cardiac origin.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 2760 (estimated)
- First submitted
- 10 Dec 2018
- Start date
- Dec 2018
- Primary completion date
- Apr 2025
- Lead sponsor
- Bispebjerg Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT03778554
- EudraCT number
- 2018-002699-42
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 2760
- From Dec 2018 to the primary completion date, Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinical evidence of heart failure at the time of discharge
- Any medical condition where beta blocker treatment is indicated according to the treating physician
Age
- Pregnancy or of child bearing age not using safe anticonception throughout the study period
Other
- Lack of signed informed consent and expected cooperation during follow-up
Who the study is looking for
- Left ventricular ejection fraction \> 40%
- Myocardial infarction (MI) within previous two weeks
- The diagnosis of acute MI must meet the Universal European Society of Cardiology (ESC) definition of MI
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bispebjerg Hospital, Dept. of Cardiology Y builing 67, 1.floor, Bispebjerg Bakke 23 Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
Related publications
- Validating national registry data for randomized trials: comparison of registry-derived cardiovascular events with and without adjudication in the BETAMI-DANBLOCK trial.Eur Heart J Qual Care Clin Outcomes · 2026 · PMID 41934630
This page is information, not medical advice. Discuss any trial with your doctor.